Inhibition of nonexocytotic norepinephrine release by desipramine reduces myocardial infarction size

Canadian Journal of Physiology and Pharmacology

Volumn 84, Issue 11, 2006, Pages 1185-1189

  Richardt, Doreen ^a   Dendorfer, Andreas ^a   Tölg, Ralph ^b   Dominiak, Peter ^a   Richardt, Gert ^b  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b Herz Kreislauf Zentrum Segeberger Kliniken GmbH   (Germany)

Author keywords

Catecholamines; Desipramine; Myocardial infarct size; Myocardial ischemia; Norepinephrine release

Indexed keywords

DESIPRAMINE; NORADRENALIN;

ADRENALIN RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EFFLUENT; ELECTROCHEMICAL DETECTION; HEART INFARCTION SIZE; HEART RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONE DETERMINATION; ISOLATED HEART; MALE; MONOAMINERGIC SYSTEM; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORONARY VESSELS; DESIPRAMINE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCHEMISTRY; LIGATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RATS; RATS, WISTAR;

EID: 33947492929     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y06-066     Document Type: Article

References (15)

1. Akiyama, T., and Yamazaki, T. 2001. Myocardial interstitial norepinephrine and dihydroxyphenylglycol levels during ischemia and reperfusion. Cardiovasc. Res. 49: 78-85. doi:10.1016/S0008-6363(00)00219-4.
2. Amitai, Y., and Fischer, H. 2004. Excess fatality from desipramine and dosage recommendations. Ther. Drug Monit. 26: 468-473.
3. Du, X.J., Woodcock, E.A., Little, P.J., Esler, M.D., and Dart, A.M. 1998. Protection of neuronal uptake-1 inhibitors in ischemic and anoxic hearts by norepinephrine-dependent and -independent mechanisms. J. Cardiovasc. Pharmacol. 32: 621-628. doi:10.1097/00005344-199810000-00015.
4. Kurz, T., Offner, B., Schreieck, J., Richardt, G., Tölg, R., and Schömig, A. 1995a. Nonexocytotic noradrenaline release and ventricular fibrillation in ischemic rat hearts. Naunyn Schmiedebergs Arch. Pharmacol. 352: 491-496.
5. Kurz, T., Richardt, G., Hagl, S., Seyfarth, M., and Schömig, A. 1995b. Two different mechanisms of noradrenaline release during normoxia and simulated ischemia in human cardiac tissue. J. Mol. Cell. Cardiol. 27: 1161-1172. doi:10.1016/0022-2828(95) 90052-7.
6. Kurz, T., Schneider, I., Tölg, R., and Richardt, G. 1999. Alpha-1-adrenergic receptor-mediated increase in the mass of phosphatide acid and 1,2-diacylglycerol in ischemic rat heart. Cardiovasc. Res. 42: 48-56. doi:10.1016/S0008-6363(98)00298-3.
7. Lameris, T.W., de Zeeuw, S., Alberts, G., Boomsma, F., Duncker, D.J., Verdouw, P., Man in't Veld, A.J., and van den Meiracker, A.H. 2000. Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. Circulation, 101: 2645-2650.
8. Remme, W.J. 1998. The sympathetic nervous system and ischaemic heart disease. Eur. Heart J. 19(Suppl. F): F62-F71.
9. Richardt, G., Blessing, R., and Schomig, A. 1994. Cardiac noradrenaline release accelerates adenosine formation in the ischemic rat heart: role of neuronal noradrenaline carrier and adrenergic receptors. J. Mol. Cell. Cardiol. 26: 1321-1328. doi:10.1006/jmcc.1994.1150.
10. Rona, G. 1985. Catecholamine cardiotoxicity. J. Mol. Cell. Cardiol. 17: 291-306.
11. Schomig, A., Fischer, S., Kurz, T., Richardt, G., and Schomig, E. 1987. Nonexocytotic release of endogenous noradrenaline in ischemic and anoxic rat heart: mechanism and metabolic requirements. Circ. Res. 60: 194-205.
12. Schomig, A., and Richardt, G. 1990. Cardiac sympathetic activity in myocardial ischemia: release and effects of noradrenaline. Basic Res. Cardiol. 85(Suppl.1): 9-30.
13. Seyfarth, M., Richardt, G., Mizsnyak, A., Kurz, T., and Schomig, A. 1996. Transient ischemia reduces norepinephrine release during sustained ischemia. Circ. Res. 78: 573-580.
14. Wolfram, S., Richardt, G., Dominiak, P., Katus, H.A., and Dendorfer, A. 2001. Apstatin, a selective inhibitor of aminopeptidase P, reduces myocardial infarct size by a kinin-dependent pathway. Br. J. Pharmacol. 134: 370-374. doi:10.1038/sj.bjp.0704236.
15. Yamamoto, S., Tamai, i., Takaoka, .M, and Matsumura, Y. 2004. Role of H3 receptors during ischemia/reperfusion in isolated rat hearts. J. Cardiovasc. Pharmacol. 43: 353-357.